Autolus Therapeutics PLCNASDAQ:AUTL
- LAST PRICE4.3900
- TODAY'S CHANGE (%)0.3200 (7.8624%)
- Bid / Lots4.3000/ 30
- Ask / Lots4.8800/ 1
- Open / Previous Close4.5000 / 4.0700
- Day Range
- 52 Week Range
- Volume2,033,189
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AUTL |
|---|---|---|
| 09:32 ET | 39811 | 4.7 |
| 09:34 ET | 54108 | 4.52 |
| 09:36 ET | 45155 | 4.69 |
| 09:38 ET | 42117 | 4.53 |
| 09:39 ET | 63943 | 4.525 |
| 09:41 ET | 33793 | 4.51 |
| 09:43 ET | 30106 | 4.65 |
| 09:45 ET | 43313 | 4.6 |
| 09:48 ET | 111348 | 4.53 |
| 09:50 ET | 8588 | 4.6 |
| 09:52 ET | 14662 | 4.545 |
| 09:54 ET | 13464 | 4.562 |
| 09:56 ET | 4312 | 4.57 |
| 09:57 ET | 12141 | 4.5404 |
| 09:59 ET | 6957 | 4.53 |
| 10:01 ET | 70430 | 4.51 |
| 10:03 ET | 8943 | 4.51 |
| 10:06 ET | 4000 | 4.49 |
| 10:08 ET | 7742 | 4.495 |
| 10:10 ET | 13341 | 4.52 |
| 10:12 ET | 14072 | 4.605 |
| 10:14 ET | 15476 | 4.5452 |
| 10:15 ET | 7116 | 4.54 |
| 10:17 ET | 7661 | 4.51 |
| 10:19 ET | 14421 | 4.52 |
| 10:21 ET | 3918 | 4.53 |
| 10:24 ET | 15479 | 4.5705 |
| 10:26 ET | 11826 | 4.59 |
| 10:28 ET | 2761 | 4.605 |
| 10:30 ET | 10222 | 4.59 |
| 10:32 ET | 5748 | 4.605 |
| 10:33 ET | 2613 | 4.575 |
| 10:35 ET | 7569 | 4.58 |
| 10:37 ET | 3707 | 4.58 |
| 10:39 ET | 4524 | 4.56 |
| 10:42 ET | 4242 | 4.55 |
| 10:44 ET | 6263 | 4.56 |
| 10:46 ET | 9309 | 4.5224 |
| 10:48 ET | 23752 | 4.475 |
| 10:50 ET | 16073 | 4.49 |
| 10:51 ET | 5609 | 4.495 |
| 10:53 ET | 12511 | 4.55 |
| 10:55 ET | 7186 | 4.51 |
| 10:57 ET | 6882 | 4.51 |
| 11:00 ET | 1132 | 4.505 |
| 11:02 ET | 4667 | 4.53 |
| 11:04 ET | 900 | 4.55 |
| 11:06 ET | 6682 | 4.58 |
| 11:08 ET | 4028 | 4.57 |
| 11:09 ET | 24166 | 4.53 |
| 11:11 ET | 8528 | 4.51 |
| 11:13 ET | 2472 | 4.525 |
| 11:15 ET | 3534 | 4.525 |
| 11:18 ET | 3581 | 4.51 |
| 11:20 ET | 3148 | 4.51 |
| 11:22 ET | 4231 | 4.5 |
| 11:24 ET | 4126 | 4.495 |
| 11:26 ET | 2639 | 4.53 |
| 11:27 ET | 15545 | 4.5992 |
| 11:29 ET | 5850 | 4.575 |
| 11:31 ET | 20394 | 4.605 |
| 11:33 ET | 3017 | 4.59 |
| 11:36 ET | 600 | 4.575 |
| 11:38 ET | 4525 | 4.585 |
| 11:40 ET | 18835 | 4.5875 |
| 11:42 ET | 12202 | 4.535 |
| 11:44 ET | 16339 | 4.505 |
| 11:45 ET | 2340 | 4.53 |
| 11:47 ET | 3729 | 4.51 |
| 11:49 ET | 5754 | 4.525 |
| 11:51 ET | 1393 | 4.52 |
| 11:54 ET | 6454 | 4.5 |
| 11:56 ET | 11887 | 4.535 |
| 11:58 ET | 1566 | 4.555 |
| 12:00 ET | 2300 | 4.565 |
| 12:02 ET | 6720 | 4.57 |
| 12:03 ET | 2837 | 4.55 |
| 12:05 ET | 600 | 4.53 |
| 12:07 ET | 6410 | 4.505 |
| 12:09 ET | 2412 | 4.53 |
| 12:12 ET | 6609 | 4.51 |
| 12:14 ET | 800 | 4.51 |
| 12:18 ET | 100 | 4.515 |
| 12:20 ET | 100 | 4.515 |
| 12:21 ET | 18508 | 4.5 |
| 12:23 ET | 1968 | 4.5 |
| 12:25 ET | 1600 | 4.505 |
| 12:27 ET | 10484 | 4.535 |
| 12:30 ET | 100 | 4.535 |
| 12:32 ET | 1300 | 4.535 |
| 12:34 ET | 4626 | 4.56 |
| 12:36 ET | 308 | 4.565 |
| 12:38 ET | 2390 | 4.575 |
| 12:39 ET | 2252 | 4.56 |
| 12:41 ET | 9450 | 4.535 |
| 12:43 ET | 300 | 4.525 |
| 12:45 ET | 3559 | 4.515 |
| 12:48 ET | 1800 | 4.51 |
| 12:50 ET | 1206 | 4.5 |
| 12:52 ET | 16627 | 4.54 |
| 12:54 ET | 1519 | 4.53 |
| 12:56 ET | 806 | 4.515 |
| 12:57 ET | 5000 | 4.505 |
| 12:59 ET | 103 | 4.505 |
| 01:01 ET | 6281 | 4.53 |
| 01:03 ET | 2400 | 4.535 |
| 01:06 ET | 10445 | 4.535 |
| 01:08 ET | 4476 | 4.51 |
| 01:10 ET | 3253 | 4.52 |
| 01:12 ET | 11133 | 4.525 |
| 01:14 ET | 2518 | 4.525 |
| 01:15 ET | 6101 | 4.535 |
| 01:17 ET | 3550 | 4.54 |
| 01:19 ET | 1661 | 4.525 |
| 01:21 ET | 1546 | 4.525 |
| 01:24 ET | 13626 | 4.5 |
| 01:26 ET | 4300 | 4.495 |
| 01:28 ET | 2606 | 4.49 |
| 01:30 ET | 1600 | 4.485 |
| 01:32 ET | 400 | 4.49 |
| 01:33 ET | 41658 | 4.505 |
| 01:35 ET | 700 | 4.505 |
| 01:37 ET | 3500 | 4.505 |
| 01:39 ET | 4423 | 4.5 |
| 01:42 ET | 100 | 4.5 |
| 01:44 ET | 4717 | 4.49 |
| 01:46 ET | 1850 | 4.4905 |
| 01:50 ET | 21456 | 4.485 |
| 01:53 ET | 3070 | 4.48 |
| 01:55 ET | 6204 | 4.475 |
| 01:57 ET | 5811 | 4.46 |
| 02:00 ET | 5022 | 4.46 |
| 02:02 ET | 8767 | 4.445 |
| 02:04 ET | 2891 | 4.455 |
| 02:06 ET | 11453 | 4.4675 |
| 02:08 ET | 7296 | 4.465 |
| 02:09 ET | 2100 | 4.46 |
| 02:11 ET | 1015 | 4.455 |
| 02:13 ET | 3697 | 4.455 |
| 02:15 ET | 18709 | 4.43 |
| 02:20 ET | 1200 | 4.435 |
| 02:22 ET | 3234 | 4.43 |
| 02:24 ET | 6615 | 4.44 |
| 02:26 ET | 4791 | 4.45 |
| 02:27 ET | 7317 | 4.46 |
| 02:29 ET | 8572 | 4.46 |
| 02:31 ET | 4524 | 4.475 |
| 02:33 ET | 13752 | 4.495 |
| 02:36 ET | 1700 | 4.495 |
| 02:38 ET | 14572 | 4.495 |
| 02:40 ET | 10125 | 4.49 |
| 02:42 ET | 900 | 4.49 |
| 02:45 ET | 6448 | 4.465 |
| 02:47 ET | 9802 | 4.485 |
| 02:49 ET | 4321 | 4.495 |
| 02:51 ET | 44306 | 4.505 |
| 02:54 ET | 9954 | 4.495 |
| 02:56 ET | 311 | 4.495 |
| 02:58 ET | 1746 | 4.485 |
| 03:00 ET | 5589 | 4.495 |
| 03:02 ET | 1110 | 4.5 |
| 03:03 ET | 9312 | 4.475 |
| 03:05 ET | 2966 | 4.47 |
| 03:07 ET | 4244 | 4.45 |
| 03:09 ET | 12895 | 4.435 |
| 03:12 ET | 10610 | 4.45 |
| 03:14 ET | 1046 | 4.445 |
| 03:16 ET | 1500 | 4.445 |
| 03:18 ET | 4560 | 4.425 |
| 03:20 ET | 15452 | 4.4305 |
| 03:21 ET | 3553 | 4.43 |
| 03:23 ET | 200 | 4.435 |
| 03:25 ET | 4654 | 4.4201 |
| 03:27 ET | 19575 | 4.41 |
| 03:30 ET | 1610 | 4.405 |
| 03:32 ET | 4201 | 4.415 |
| 03:34 ET | 10112 | 4.435 |
| 03:36 ET | 3421 | 4.425 |
| 03:38 ET | 2200 | 4.415 |
| 03:39 ET | 11467 | 4.425 |
| 03:41 ET | 4576 | 4.435 |
| 03:43 ET | 500 | 4.435 |
| 03:45 ET | 13990 | 4.435 |
| 03:48 ET | 7929 | 4.425 |
| 03:50 ET | 9475 | 4.425 |
| 03:52 ET | 1694 | 4.425 |
| 03:54 ET | 25819 | 4.425 |
| 03:56 ET | 13536 | 4.42 |
| 03:57 ET | 13147 | 4.41 |
| 03:59 ET | 90592 | 4.39 |
May 17, 2024
DJ Autolus Therapeutics Price Target Maintained With a $9.00/Share by Needham, from 1:52PM ET on Friday May 17, 2024 by Dow Jones
1:52PM ET on Friday May 17, 2024 by Dow Jones*DJ Autolus Therapeutics 1Q Loss/Shr 24c >AUTL, from 7:00AM ET on Friday May 17, 2024 by Dow Jones
7:00AM ET on Friday May 17, 2024 by Dow JonesAutolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates, from 7:00AM ET on Friday May 17, 2024 by Dow Jones
7:00AM ET on Friday May 17, 2024 by Dow Jones
May 14, 2024
Autolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress, from 10:00AM ET on Tuesday May 14, 2024 by Dow Jones
10:00AM ET on Tuesday May 14, 2024 by Dow Jones
May 13, 2024
*DJ Autolus Therapeutics Announces Delay to Its 1Q 2024 Earnings Release and Conference Call, from 7:01AM ET on Monday May 13, 2024 by Dow Jones
7:01AM ET on Monday May 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Autolus Therapeutics PLC | 1.2B | -3.7x | --- |
Pharvaris NV | 1.1B | -7.4x | --- |
Gyre Therapeutics Inc | 1.2B | -0.7x | --- |
Cassava Sciences Inc | 1.1B | -19.8x | --- |
Enliven Therapeutics Inc | 1.1B | -10.6x | --- |
Verona Pharma PLC | 1.1B | -16.4x | --- |
Company Information
Autolus Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. It is focused on chimeric antigen receptor (CAR)-T cell therapy. Using a suite of proprietary and modular T cell programming technologies, it is engineering targeted, controlled and highly active T cell therapy product candidates that are designed to recognize target cells, break down their defense mechanisms and eliminate these cells. It has a pipeline of product candidates in development for the treatment of hematological malignancies, solid tumors and autoimmune diseases. Its products pipeline includes obe-cel (FELIX), obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting T Cell Receptor Beta Constant (TRBC) 1 and TRBC 2.
Contact Information
- Headquarters
- The Mediaworks, 191 Wood LaneLONDON, United Kingdom W12 7FP
- Phone
- 203-829-6230
- Fax
- ---
Executives
- Chairman of the Board
- Michael Bonney
- Chief Executive Officer, Executive Director
- Christian Itin
- Founder, Senior Vice President, Chief Scientific Officer
- Martin Pule
- Chief Financial Officer, Senior Vice President
- Lucinda Crabtree
- Chief Operating Officer, Senior Vice President
- Christopher Vann
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
|---|---|
Revenue (TTM) | $1.7M |
Shares Outstanding | 265.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.03 |
EPS | $-1.20 |
Book Value | --- |
P/E Ratio | -3.7x |
Price/Sales (TTM) | 687.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -10,583.10% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
